R D Molano

Author PubWeight™ 21.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001 1.43
2 Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001 1.42
3 Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 2007 1.11
4 Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 2001 0.96
5 Anti-inflammatory properties of exenatide in human pancreatic islets. Cell Transplant 2011 0.94
6 Islet cell transplantation: in vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 2000 0.88
7 Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 2001 0.87
8 A functional CD40 receptor is expressed in pancreatic beta cells. Diabetologia 2005 0.86
9 Rapamycin impairs beta-cell proliferation in vivo. Transplant Proc 2008 0.84
10 Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001 0.84
11 Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts. Transplant Proc 2008 0.83
12 HO-1 upregulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis. Transplant Proc 2001 0.82
13 Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations. Cell Transplant 2010 0.82
14 Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation. Pharmazie 2010 0.81
15 beta-Cell specific cytoprotection by prolactin on human islets. Transplant Proc 2008 0.81
16 Early assessment of apoptosis in isolated islets of Langerhans. Transplant Proc 2001 0.80
17 Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment. Am J Transplant 2013 0.80
18 c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. Diabetologia 2008 0.80
19 Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. Transplant Proc 2009 0.79
20 Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. Clin Exp Immunol 2008 0.79
21 Soft corticosteroids for local immunosuppression: exploring the possibility for the use of loteprednol etabonate for islet transplantation. Pharmazie 2008 0.79
22 Evaluation of viable β-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI. Cell Transplant 2011 0.78
23 Effects of pancreas cold ischemia on islet function and quality. Transplant Proc 2009 0.78
24 Ischemic preconditioning improves islet recovery after pancreas cold preservation. Transplant Proc 2009 0.77
25 Absence of M-CSF-dependent tissue macrophages does not improve delayed function of islet of Langerhans grafts. Transplant Proc 2001 0.75
26 Absence of CSF-1-dependent macrophages does not improve function of transplanted islets of Langerhans. Cell Transplant 2001 0.75
27 Differential engraftment of human peripheral blood lymphocytes in various strains of immunodeficient mice. Transplant Proc 2001 0.75